Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 25%
Buy 40%
Hold 35%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a strong and diversified company in the medical technology sector with a successful M&A strategy, a target price of $74, strong revenue growth, and plans for continued growth through new product launches and strategic acquisitions. While there are some potential risks, the company is well-positioned to weather challenges such as competition, global volatility, and supply chain disruptions, and has a track record of returning cash to shareholders through dividends and share purchases.

Bears say

Medtronic is facing risks to its EPS growth and ROIC if capital is not allocated wisely and there are slow product growth and competition in the global market. Recent investments in the cardiovascular and medical surgical industries could bring potential growth opportunities, but there are also potential risks from macroeconomic factors and global economic challenges. Despite these challenges, Medtronic remains a leader in the MedTech industry with a diverse workforce and strong potential for growth in US sales and various growth drivers.

Medtronic (MDT) has been analyzed by 20 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 40% recommend Buy, 35% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 20 analysts, Medtronic (MDT) has a Buy consensus rating as of Jun 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $102.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $102.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.